PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1499627
PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1499627
In-hospital Care Challenges and Promising Hospital-at-home Outcomes Will Spur Future Growth Potential
The hospital-at-home (HaH) care model provides hospital-grade care in a home setting for acute patients with conditions ranging from asthma and pneumonia to congestive heart failure. This analysis will cover market size and forecast at the solution level, including technological solutions and care coordination services for acute care management HaH implementation. The geographic coverage is global, and the study period is from 2023 to 2029, while the forecast period extends from 2024 to 2029. Frost & Sullivan has identified three growth opportunities for industry stakeholders to seize.
This business model promises to help hospitals and health systems in general overcome workforce shortages and capacity issues. Studies and evaluations demonstrate that the HaH's outcomes are equivalent to or on par with in-hospital care, garnering attention from all stakeholders. Other improvement parameters include reductions in costs, hospital readmission rates, risks of hospital-acquired infections, bed capacity, operational efficiency, and patient recovery time. HaH is, therefore, a viable alternative for healthcare players to provide quality care outside of the hospital setting.